Skip to main content
Log in

Two successfully completed pregnancies in adult onset Pompe disease, under continued treatment with alglucosidase alfa

  • Letter to the Editor
  • Published:
Acta Neurologica Belgica Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

References

  1. Chan J, Desai AK, Kazi ZB, Corey K, Austin S, Hobson-Webbb LD, Case LE, Jones HN, Kishnani PS (2017) The emerging phenotype of late-onset Pompe disease: a systematic literature review. Mol Genet Metab 120(3):163–172

    Article  CAS  PubMed  Google Scholar 

  2. Rohman PJ, Scott E, Richfield L, Ramaswami U, Hughes DA (2016) Pregnancy and associated events in women receiving enzyme replacement therapy for late-onset glycogen storage disease type II (Pompe disease). J Obstet Gynaecol 42(10):1263–1271

    CAS  Google Scholar 

  3. Papadopoulos C et al (2017) Effect of enzyme replacement therapy with alglucosidase alfa (Myozyme®) in 12 patients with advanced late-onset Pompe disease. Mol Genet Metab 122(1–2):80–85

    Article  CAS  PubMed  Google Scholar 

  4. Stepien KM, Hendriksz CJ, Roberts M, Sharma R (2016) Observational clinical study of 22 adult-onset Pompe disease patients undergoing enzyme replacement therapy over 5 years. Mol Genet Metab 117(4):413–418

    Article  CAS  PubMed  Google Scholar 

  5. de Vries JM, Brugma JDC, Özkan L, Steegers EAP, Reuser AJJ, van Doorn PA, van der Ploeg AT (2011) First experience with enzyme replacement therapy during pregnancy and lactation in Pompe disease. Mol Genet Metab 104(4):552–555

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jan L. De Bleecker.

Ethics declarations

Conflict of interest

None of the authors has anything to report regarding this article.

Ethical approval

This article does not describe any studies performed on human participants or animals.

Informed consent

The patient approved in writing reporting the observations to the medical community and to a dedicated pregnancy registry for Myozyme-treated patients.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Van Houtte, J., De Bleecker, J.L. Two successfully completed pregnancies in adult onset Pompe disease, under continued treatment with alglucosidase alfa. Acta Neurol Belg 119, 147–149 (2019). https://doi.org/10.1007/s13760-019-01089-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13760-019-01089-4

Keywords

Navigation